Sleep medications explained

What sleep medications are

Sleep medications are a group of drugs used to help people fall asleep, stay asleep, or both. What makes the group unusual is that it is not really one class at all. It is a collection of medications, drawn from several different drug families, that happen to share the practical goal of improving sleep.

Some of these medications were designed specifically as sleep aids. Others, such as several of the sedating antidepressants, were developed for other purposes and turned out to be useful for sleep at low doses. Because the group is assembled this way, the medications inside it work through different mechanisms and carry different risks. Understanding that variety is the key to understanding the group.

How they work

Sleep medications use several different routes to nudge a person toward sleep, and the route matters.

One large group strengthens GABA, the brain's main calming chemical messenger. The z-drugs (zolpidem, eszopiclone, and zaleplon) and the benzodiazepine temazepam all act on the GABA-A receptor, though the z-drugs bind more selectively to a sedation-tied subtype.

Another group blocks histamine. Histamine is part of what keeps the brain alert, and it is the same drowsiness pathway behind sedating antihistamines. Sedating antidepressants used for sleep, such as trazodone, low-dose doxepin, and amitriptyline, block histamine, as do the over-the-counter antihistamines sold for sleep.

A third approach works on the body clock through melatonin receptors. Melatonin is the body's evening night signal, and ramelteon, along with melatonin itself, acts on those receptors rather than sedating the brain directly.

The newest approach blocks orexin, the brain's wakefulness signal. Instead of pushing the brain toward sleep, suvorexant turns down the signal that keeps it awake.

How sleep medications developed

The history of sleep medications is, in plain terms, a long search for something that helps with sleep without causing too much harm along the way.

The earliest sleep aids were older sedatives, and the most important of them were the barbiturates. They worked, in the sense that they reliably made people drowsy. The problem was the narrow safety margin. The gap between a dose that helped a person sleep and a dose that dangerously slowed breathing was small. Overdose was a serious risk, and that risk grew sharply when barbiturates were combined with alcohol. They could also cause heavy dependence. For decades there was not a better option, but the dangers were real.

Benzodiazepines, introduced in the 1960s, were the next step. Several of them, including temazepam, were used for sleep. They were a genuine improvement on barbiturates, mainly because the safety margin was wider and overdose on a benzodiazepine alone was far less likely to be fatal. Over time, though, a clearer picture of tolerance, physical dependence, and difficult withdrawal emerged, and prescribing became more cautious.

The z-drugs, which arrived in the 1990s, were designed in response to that picture. The idea was to act on the same GABA system as benzodiazepines but to bind more selectively to the receptor subtype most tied to sedation, in the hope of getting the sleep benefit with fewer of the other effects. The z-drugs are useful, and they are widely used, but experience has shown they still carry dependence risk and their own cautions, including complex sleep behaviors.

More recent approaches took different routes entirely. The melatonin receptor agonist ramelteon works on the body clock rather than sedating the brain, which is part of why it is not habit-forming. The orexin blocker suvorexant turns down the brain's wakefulness signal instead of forcing the brain toward sleep. These newer mechanisms were attempts to help with sleep while sidestepping some of the older problems.

Running alongside this whole story is a quieter but important shift. As the limits of medication became clearer, the evidence for a non-drug approach grew. Cognitive behavioral therapy for insomnia, known as CBT-I, is now recognized as the first-line treatment for chronic insomnia. It is not a drug, it works at least as well as medication, and its benefit lasts after treatment ends. The arc of the history, then, is not only newer pills. It is also a growing recognition that the best first answer for long-term insomnia often is not a pill at all.

What they treat

Sleep medications are used mainly for short-term and situational insomnia. That covers trouble falling asleep, trouble staying asleep, or both.

Which drug fits depends in part on the shape of the problem. Some medications are better suited to falling asleep, some to staying asleep, and some to both. A prescriber uses that distinction to narrow the choice. Insomnia tied to a clear short-term cause, such as travel, a stressful stretch, or a brief disruption to routine, is the kind of situation where a short course of medication is most clearly appropriate.

What they have in common

For a group this varied, it is worth being clear about the themes that run across nearly all of it.

• Most work best short-term. With few exceptions, sleep medications are intended for short stretches or specific situations rather than indefinite nightly use. Their usefulness is clearest in the short term.
• Most can leave next-day grogginess. Many sleep medications, especially the longer-acting ones, can carry sedation into the next morning. That can affect alertness, driving, and daily functioning, particularly when a dose is taken too late or is higher than needed.
• Several carry dependence risk. The z-drugs, the benzodiazepine temazepam, and suvorexant are controlled substances and carry dependence risk to varying degrees. Tolerance, where the same dose works less well over time, is part of the same concern. Not every sleep medication carries this risk, but enough of them do that it is a shared theme.
• Older adults are more sensitive to all of them. Older adults tend to feel the effects of sleep medications more strongly and clear them more slowly. That raises the risk of daytime drowsiness, confusion, and falls. Many sleep medications appear on the Beers list, a guide to medications to use with extra caution in older adults.
• None treats the cause of insomnia. This is the most important shared point. A sleep medication can help a person sleep on a given night, but it does not address whatever is keeping that person awake in the first place. When sleep medication is stopped, the underlying problem is usually still there unless it has been addressed another way.

None of this means sleep medications are unsafe or useless. It means they are best understood as tools for specific jobs, used with a plan and a prescriber, rather than a long-term fix.

Why they are usually short-term, and what comes first

This is the honest core of the page. For insomnia that has lasted weeks or longer, the first-line treatment is not a medication. It is CBT-I, cognitive behavioral therapy for insomnia. CBT-I works at least as well as medication, and the benefit lasts longer after treatment ends, which is something no sleeping pill can claim.

Steady sleep and wake times and good sleep habits matter too. They are not a glamorous answer, but they are part of the foundation. Medication is best used for short stretches, for specific situations, or alongside CBT-I rather than instead of it.

There are two reasons for that limited role. Some sleep medications carry a real risk of dependence. And even the ones that don't are generally not meant to replace addressing whatever is keeping a person awake in the first place. At the same time, ongoing poor sleep is worth taking seriously. So this is not an argument against ever using medication. It is a reason to be clear about what role the medication is playing.

The main types of sleep medication

It helps to walk through the main types, because they are genuinely different from one another.

The z-drugs are zolpidem, eszopiclone, and zaleplon. They are controlled substances, and they carry an FDA boxed warning about complex sleep behaviors, such as walking, eating, or driving while not fully awake.

The benzodiazepine temazepam is also a controlled substance. It carries a real risk of tolerance, physical dependence, and difficult withdrawal, the same concerns that apply across the benzodiazepine class.

Sedating antidepressants are used for sleep at low doses. This group includes trazodone, low-dose doxepin, amitriptyline, and mirtazapine. They are not controlled substances and do not carry the dependence risk of the z-drugs or temazepam.

The melatonin receptor agonist ramelteon works on the body clock rather than sedating the brain. It is not a controlled substance and is considered non-habit-forming.

The orexin blocker suvorexant uses a newer mechanism, turning down the brain's wakefulness signal. It is a controlled substance.

Over-the-counter and natural options round out the picture. These include antihistamines, melatonin, and herbal products. They are easy to reach for, but the evidence behind them is mixed, and PsychiatryRx has a separate guide that looks at them honestly.

How a prescriber chooses one

Choosing a sleep medication starts with a few practical questions. Is the trouble mainly falling asleep, staying asleep, or both. How old is the person, since older adults need extra caution and many sleep drugs are on the Beers list of medicines to use carefully in older adults. What other health conditions and medications are in the picture. Is there any history of substance use. And how long is treatment likely to be needed.

From there, a prescriber generally favors the option with the least risk that still fits the problem, at the lowest effective dose for the shortest reasonable time.

The medications in this section

• Zolpidem (Ambien). A z-drug, controlled substance, used mainly for falling asleep.
• Eszopiclone (Lunesta). A z-drug, controlled substance, longer-acting and used for staying asleep.
• Zaleplon (Sonata). A z-drug, controlled substance, very short-acting and used for falling asleep.
• Temazepam (Restoril). A benzodiazepine, controlled substance, with real dependence and withdrawal risk.
• Ramelteon (Rozerem). A melatonin receptor agonist, not a controlled substance, non-habit-forming.
• Suvorexant (Belsomra). An orexin blocker, controlled substance, with a newer mechanism.
• Doxepin (Silenor). A sedating antidepressant used at low doses for sleep, not a controlled substance.
• Amitriptyline (Elavil). An older antidepressant, sedating, sometimes used off-label for sleep.
• Trazodone (Desyrel). An antidepressant widely used at low doses for sleep, not a controlled substance.
• Mirtazapine (Remeron). A sedating antidepressant, not a controlled substance.

For antihistamines, melatonin, and herbal products, see the PsychiatryRx guide on over-the-counter and natural sleep aids.

PsychiatryRx has dedicated pages for these medications, with more detail on uses, risks, dosing, and what to expect.

Common questions

Are sleep medications safe? They can be used safely, and for the right situation they are useful. They differ a lot, though. The z-drugs and temazepam carry dependence risk and need more care, while ramelteon and the sedating antidepressants do not. Used at the lowest effective dose, for a defined period, and with a prescriber, the risks of any of them can be managed better.

Which sleep medications are habit-forming? The z-drugs (zolpidem, eszopiclone, zaleplon), the benzodiazepine temazepam, and suvorexant are controlled substances and carry dependence risk to varying degrees. Ramelteon and the sedating antidepressants, such as trazodone, doxepin, amitriptyline, and mirtazapine, are not controlled substances and do not cause that kind of dependence.

What is CBT-I? CBT-I is cognitive behavioral therapy for insomnia, a structured, fairly short, non-drug program that retrains the habits and thoughts keeping sleep broken. It is the recommended first-line treatment for chronic insomnia, it works at least as well as medication, and the benefit lasts longer after it ends.

Do sleep medications fix the cause of insomnia? No. They can help a person sleep on a given night, but they do not treat whatever is driving the insomnia. That is one of the main reasons they are used short-term and why addressing the underlying cause, often through CBT-I, matters.

Should I take a sleep medication every night? For most people the honest answer is no, not as a long-term plan. Sleep medications are best for short stretches or specific situations. Ongoing nightly use is usually a sign that the underlying sleep problem needs a closer look, and that is a conversation to have with a prescriber.

Sources

This guide draws on current prescribing information and public health references. It is reviewed for clinical accuracy and updated as guidance changes.

1. U.S. Food and Drug Administration. Prescribing information.
2. MedlinePlus, U.S. National Library of Medicine.
3. National Institute of Mental Health. Mental health medications.